Carson Otto, Author at Segra International
Segra International is a plant biotechnology company that specializes in industrial-scale cannabis plant micropropagation. The company is developing industrial-scale cannabis micropropagation laboratories to produce healthy, robust plantlets for licensed cannabis producers globally.
Segra, Cannabis Micropropagation, Cannabis Tissue Culture, Research and Development, R&D, Quality Management Systems, facilities, plant-based medicines, medicinal, Cannabis, botanical, tissue culture, specialist, Genotyping Services, Tissue Culture Production, Modular Growing Facility, Micropropagation
archive,author,author-carson-ottosegra-intl-com,author-9,ajax_fade,page_not_loaded,,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

Author: Carson Otto


VANCOUVER, March 26, 2020 — Segra International Corp., a cannabis agriculture technology company, is pleased to announce the appointment of Jamie Blundell as Chief Executive Officer effective March 23, 2020.  Founding CEO, Todd McMurray, recognized the time was right to bring in a proven global...

VANCOUVER, BRITISH COLUMBIA, December 5th, 2019 - Segra International Corp. ("Segra") is pleased to announce that it has entered into a strategic plant genotyping and tissue culture agreement with Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT, SUGR.RT) ("Sugarbud")  through its wholly owned subsidiary Segra Biogenesis Corp. Under...